These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 8196467

  • 1. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E.
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [Abstract] [Full Text] [Related]

  • 2. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Mar; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 3. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
    Bown RL.
    Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
    [Abstract] [Full Text] [Related]

  • 4. Clinical review of lansoprazole.
    Lockhart SP.
    Br J Clin Pract Suppl; 1994 Mar; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [Abstract] [Full Text] [Related]

  • 5. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
    Mignon M, Hochlaf S, Forestier S, Ruszniewski P, Vatier J, Joubert-Collin M.
    Gastroenterol Clin Biol; 1994 Mar; 18(1):13-6. PubMed ID: 8187984
    [Abstract] [Full Text] [Related]

  • 6. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 7. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M, Pospai D, Forestier S, Vatier J, Vallot T.
    Clin Ther; 1993 Apr; 15 Suppl B():22-31. PubMed ID: 8205592
    [Abstract] [Full Text] [Related]

  • 8. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB, Faulds D, McTavish D.
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [Abstract] [Full Text] [Related]

  • 9. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Aug; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 10. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Aug; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 11. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
    Schütze K, Hentschel E.
    Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
    [Abstract] [Full Text] [Related]

  • 12. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N.
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [Abstract] [Full Text] [Related]

  • 13. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 14. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
    Gremse DA.
    Expert Opin Pharmacother; 2001 Oct; 2(10):1663-70. PubMed ID: 11825309
    [Abstract] [Full Text] [Related]

  • 15. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
    Ramón Nogueira J, Esquivel Ayanegui F, Esquivel Rodríguez F, Sáenz V, Santoyo R.
    Rev Gastroenterol Mex; 1996 Oct; 61(4):314-9. PubMed ID: 9072782
    [Abstract] [Full Text] [Related]

  • 16. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J, Laskowiec G.
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [Abstract] [Full Text] [Related]

  • 17. [Lansoprazol].
    Ponce J, Nos P.
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract] [Full Text] [Related]

  • 18. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL, Dorsch E, Jones J, Jennings DE, Greski-Rose PA.
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [Abstract] [Full Text] [Related]

  • 19. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R.
    Fortschr Med; 1994 Jan 20; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract] [Full Text] [Related]

  • 20. Clinical utility and safety of omeprazole.
    Walan A.
    Methods Find Exp Clin Pharmacol; 1989 Jan 20; 11 Suppl 1():107-11. PubMed ID: 2657279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.